L. Xi

Clinical pharmacokinetics, pharmacodynamics, safety, and tolerability of JNJ-54175446, a brain permeable P2X7 antagonist, in a randomised single-ascending dose study in healthy participants

M. Furey, G. Triana-Baltzer, A. Bhattacharya, 2018, Journal of psychopharmacology.

Effect of intranasal esketamine on cognitive functioning in healthy participants: a randomized, double-blind, placebo-controlled study

W. Drevets, J. V. van Gerven, Jaskaran Singh, 2016, Psychopharmacology.

Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study

Husseini Manji, Frank Wiegand, Wayne C. Drevets, 2016, Biological Psychiatry.

Efficacy and Safety of Intravenous Esketamine in Patients with Treatment-resistant Depression: A Double-blind, Double-randomization, Placebo-controlled Phase 2a Study

W. Drevets, P. Sienaert, H. Manji, 2013 .